Adial Pharmaceuticals Inc (ADIL)

$0.33 +0.01 (4.73%)
Market Cap 7.51M
Revenue (ttm) 0.00
Net Income (ttm) -13.20M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 364,700
Avg Vol 558,618
Day's Range N/A - N/A
Shares Out 23.99M
Stochastic %K 72%
Beta 1.11
Analysts Strong Sell
Price Target $2.17

Company Profile

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. The company's lead product is AD04, a serotonin-3 antagonist, which is in Phase 3 clinical trials for the treatment of alcohol use disorder. It is also involved in the development of drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and i...

Industry: Biotechnology
Sector: Healthcare
Phone: (804) 487-8196
Address:
4870 Sadler Road, Suite 300, Glen Allen, United States
dln101
dln101 Dec. 4 at 8:40 PM
$TOVX znext penny to bounce 👉 $ADIL or $AZTR 🤔💪🔥🚀
0 · Reply
DylanCross
DylanCross Dec. 4 at 7:56 PM
$ADIL For me the bull case short term is simple millions of shares rotated near the lows tighter and tighter intraday range on Next NRG and buyers quietly soaking everything under 1.25 if volume spikes back toward yesterday levels I am expecting a push to new short term highs 🚀
0 · Reply
Mikemelga2024
Mikemelga2024 Dec. 3 at 5:45 PM
$ADIL
1 · Reply
Mahdinur
Mahdinur Dec. 3 at 12:56 AM
$ADIL longer wait $GRI primed
0 · Reply
StayPresent
StayPresent Dec. 1 at 1:06 PM
$ADIL I believe they have extension to March to meet min price. If you’ve followed this company, they are a dilution machine the last 2 yrs with the occasional p&d mixed in. POS management team who are waiting for a miracle partner to save them.
0 · Reply
TWITLIEDETECTOR
TWITLIEDETECTOR Nov. 29 at 3:46 AM
$ADIL isn’t this stock close to an RS? there’s a lot of stocks ready to rs. it’s bad
1 · Reply
Last_Short
Last_Short Nov. 28 at 10:28 AM
$ADIL extremely bullish position on ADIL 0.3 was bottom and was filled quick from 0.25 instant drop bullish short term
0 · Reply
Mikemelga2024
Mikemelga2024 Nov. 26 at 1:08 PM
$ADIL https://finance.yahoo.com/news/adial-pharmaceuticals-announces-warrant-inducement-130000798.html
0 · Reply
Tdsager
Tdsager Nov. 26 at 12:38 PM
$$ADIL lot of shares traded yesterday,and now up today premarket.maybe could run ,will see GLTA
0 · Reply
Mikemelga2024
Mikemelga2024 Nov. 25 at 9:18 PM
$ADIL shit day
0 · Reply
Latest News on ADIL
Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show

Oct 17, 2025, 9:00 AM EDT - 7 weeks ago

Adial Pharmaceuticals CEO was a Featured Guest on The Big Biz Show

Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution

Oct 9, 2025, 8:30 AM EDT - 2 months ago

Adial Pharmaceuticals Partners with Genomind for Precision Medicine Testing Solution

Adial Pharmaceuticals Provides Business Update Following Favorable Comments from FDA End-of-Phase 2 (EOP2) Meeting for AD04

Sep 16, 2025, 8:00 AM EDT - 2 months ago

Adial Pharmaceuticals Provides Business Update Following Favorable Comments from FDA End-of-Phase 2 (EOP2) Meeting for AD04

Adial Pharmaceuticals Granted a 180 Calendar Day Extension by Nasdaq to Regain Compliance with the Minimum Bid Price Rule

Sep 3, 2025, 8:30 AM EDT - 3 months ago

Adial Pharmaceuticals Granted a 180 Calendar Day Extension by Nasdaq to Regain Compliance with the Minimum Bid Price Rule

Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 14, 2025, 8:30 AM EDT - 4 months ago

Adial Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting

Aug 6, 2025, 8:00 AM EDT - 4 months ago

Adial Pharmaceuticals Completes Successful EOP2 FDA Meeting

Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement

Jul 16, 2025, 8:30 AM EDT - 5 months ago

Adial Pharmaceuticals Regains Compliance with Nasdaq Stockholders' Equity Listing Requirement

Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045

Jul 9, 2025, 8:30 AM EDT - 5 months ago

Adial Pharmaceuticals Files PCT Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to at least 2045

Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply

Jun 25, 2025, 8:30 AM EDT - 5 months ago

Adial Pharmaceuticals Secures U.S.-Based Manufacturing Through Agreements with Cambrex and Thermo Fisher Scientific for Drug Substance and Drug Product Supply

Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

May 15, 2025, 8:30 AM EDT - 7 months ago

Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study

May 13, 2025, 8:30 AM EDT - 7 months ago

Adial Pharmaceuticals Receives Milestone Payment from Adovate Following Initiation of Phase 1 Study

Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds

May 2, 2025, 11:48 AM EDT - 7 months ago

Adial Pharmaceuticals Announces a Warrant Inducement Transaction for $2.75 Million in Gross Proceeds

Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders

May 1, 2025, 8:30 AM EDT - 7 months ago

Adial Pharmaceuticals Expands Intellectual Property Portfolio with New U.S. Patent Granted for Genetic-Based Treatment of Alcohol and Opioid Use Disorders

Adial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business Update

Mar 4, 2025, 8:30 AM EST - 9 months ago

Adial Pharmaceuticals Reports 2024 Fiscal Year Financial Results and Provides Business Update

Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04

Feb 25, 2025, 9:00 AM EST - 10 months ago

Adial Pharmaceuticals Receives Positive Response from FDA Meeting Regarding Proposed In Vitro Bridging Strategy for AD04

Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies

Feb 19, 2025, 9:00 AM EST - 10 months ago

Adial Pharmaceuticals Granted New U.S. Patent Expanding Coverage of its Genetic-Based Approach to Treating and Diagnosing Alcohol Use Disorder and Other Drug Dependencies

Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders

Feb 12, 2025, 9:00 AM EST - 10 months ago

Adial Pharmaceuticals Awarded New U.S. Patent Covering Genotype-Specific Treatment of Opioid-Related Disorders

Adial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Jan 29, 2025, 9:00 AM EST - 11 months ago

Adial Pharmaceuticals Announces Positive Clinical Study Results from the AD04-103 Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations

Dec 3, 2024, 8:30 AM EST - 1 year ago

Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer

Nov 5, 2024, 8:30 AM EST - 1 year ago

Adial Pharmaceuticals Appoints Vinay Shah as Chief Financial Officer

Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Sep 19, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Announces Database Lock in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Sep 4, 2024, 9:00 AM EDT - 1 year ago

Adial Pharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 14, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Aug 7, 2024, 9:00 AM EDT - 1 year ago

Adial Pharmaceuticals Announces Last Patient Dosed in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044

Jul 31, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Files New Patent Application to Protect Core Assets and Extend IP Exclusivity on Core Technology to 2044

Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Jul 23, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Advances to Second Cohort in Pharmacokinetics Study of AD04 for the Treatment of Alcohol Use Disorder

Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder

Jun 20, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder

Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th

May 29, 2024, 8:30 AM EDT - 1 year ago

Adial CEO to Present at the Spring MicroCap Rodeo Conference on June 6th

Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

May 15, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office

Apr 22, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Granted Key Patent from the United States Patent and Trademark Office

Adial Pharmaceuticals posts promising update on alcohol disorder drug

Apr 10, 2024, 2:15 PM EDT - 1 year ago

Adial Pharmaceuticals posts promising update on alcohol disorder drug

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder

Apr 10, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Announces Peer-Reviewed Publication Highlighting Promising Safety Data and High Patient Compliance in a Clinical Trial of AD04 as a Potential Treatment for Alcohol Use Disorder

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update

Apr 2, 2024, 8:30 AM EDT - 1 year ago

Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds

Mar 1, 2024, 7:00 PM EST - 1 year ago

Adial Pharmaceuticals Announces Exercise of Warrants for $3.5 Million Gross Proceeds

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office

Feb 28, 2024, 9:30 AM EST - 1 year ago

Adial Pharmaceuticals Awarded New Patent from the United States Patent and Trademark Office

Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20

Feb 15, 2024, 9:00 AM EST - 1 year ago

Adial Pharmaceuticals to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20

Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office

Feb 13, 2024, 9:15 AM EST - 1 year ago

Adial Pharmaceuticals Awarded New Patent Notice of Allowance from the United States Patent and Trademark Office

Adial Announces Appointment of Tony Goodman as Chief Operating Officer

Jan 18, 2024, 8:30 AM EST - 2 years ago

Adial Announces Appointment of Tony Goodman as Chief Operating Officer

Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate

Dec 20, 2023, 9:00 AM EST - 2 years ago

Adial Pharmaceuticals Receives Final Reimbursement Payment from Adovate

Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement

Nov 29, 2023, 4:05 PM EST - 2 years ago

Adial Pharmaceuticals Regains Compliance with Nasdaq Listing Requirement

Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 14, 2023, 5:02 PM EST - 2 years ago

Adial Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update

Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conference

Oct 31, 2023, 8:30 AM EDT - 2 years ago

Adial Pharmaceuticals Chief Medical Officer and Key Opinion Leaders to Discuss “New Aspects in Substance Use Treatment” at The Annual International Society of Addiction Medicine Conference

Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader Webinar

Oct 25, 2023, 8:00 AM EDT - 2 years ago

Addiction Experts Highlight the Need for Non-Abstinence-Based Therapies to Treat Alcohol Use Disorder in Adial Pharmaceuticals Key Opinion Leader Webinar

Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Oct 24, 2023, 4:30 PM EDT - 2 years ago

Adial Pharmaceuticals Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Oct 20, 2023, 8:00 AM EDT - 2 years ago

Adial Pharmaceuticals Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Adial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25th

Oct 19, 2023, 12:00 PM EDT - 2 years ago

Adial Pharmaceuticals to Present at the Fall Foliage MicroCap Rodeo Conference on October 25th

Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company's Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug Dependence

Oct 19, 2023, 10:30 AM EDT - 2 years ago

Adial Pharmaceuticals Awarded Notice of Allowance for Key Patent Combining Use of the Company's Proprietary Genetic Diagnostic with AD04 to Treat Alcohol and Drug Dependence

Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award

Oct 18, 2023, 8:00 AM EDT - 2 years ago

Adial Pharmaceuticals Wins Frost & Sullivan's 2023 North American Precision Medicine for Addiction Disorders Technology Innovation Leadership Award

Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use Disorder

Sep 28, 2023, 7:00 AM EDT - 2 years ago

Adial Pharmaceuticals to Host a Virtual Key Opinion Leader Webinar to Discuss the Unmet Need in Alcohol Use Disorder

Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Sep 5, 2023, 8:30 AM EDT - 2 years ago

Adial Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

dln101
dln101 Dec. 4 at 8:40 PM
$TOVX znext penny to bounce 👉 $ADIL or $AZTR 🤔💪🔥🚀
0 · Reply
DylanCross
DylanCross Dec. 4 at 7:56 PM
$ADIL For me the bull case short term is simple millions of shares rotated near the lows tighter and tighter intraday range on Next NRG and buyers quietly soaking everything under 1.25 if volume spikes back toward yesterday levels I am expecting a push to new short term highs 🚀
0 · Reply
Mikemelga2024
Mikemelga2024 Dec. 3 at 5:45 PM
$ADIL
1 · Reply
Mahdinur
Mahdinur Dec. 3 at 12:56 AM
$ADIL longer wait $GRI primed
0 · Reply
StayPresent
StayPresent Dec. 1 at 1:06 PM
$ADIL I believe they have extension to March to meet min price. If you’ve followed this company, they are a dilution machine the last 2 yrs with the occasional p&d mixed in. POS management team who are waiting for a miracle partner to save them.
0 · Reply
TWITLIEDETECTOR
TWITLIEDETECTOR Nov. 29 at 3:46 AM
$ADIL isn’t this stock close to an RS? there’s a lot of stocks ready to rs. it’s bad
1 · Reply
Last_Short
Last_Short Nov. 28 at 10:28 AM
$ADIL extremely bullish position on ADIL 0.3 was bottom and was filled quick from 0.25 instant drop bullish short term
0 · Reply
Mikemelga2024
Mikemelga2024 Nov. 26 at 1:08 PM
$ADIL https://finance.yahoo.com/news/adial-pharmaceuticals-announces-warrant-inducement-130000798.html
0 · Reply
Tdsager
Tdsager Nov. 26 at 12:38 PM
$$ADIL lot of shares traded yesterday,and now up today premarket.maybe could run ,will see GLTA
0 · Reply
Mikemelga2024
Mikemelga2024 Nov. 25 at 9:18 PM
$ADIL shit day
0 · Reply
Perfect_Thinking
Perfect_Thinking Nov. 24 at 5:14 PM
$ADIL something is coming sooner getting its mark..fda
1 · Reply
Last_Short
Last_Short Nov. 21 at 9:58 PM
$ADIL bearish r\S incoming also 0.1
2 · Reply
Mikemelga2024
Mikemelga2024 Nov. 21 at 2:46 PM
$ADIL volume increased
0 · Reply
dln101
dln101 Nov. 21 at 1:10 PM
$ADIL ppenny itching to friday short squeeze 100% $ENDPQ $ENLV style 🤔💪🔥🚀
0 · Reply
dogood
dogood Nov. 21 at 11:22 AM
$ADIL don’t know any criminal traders are all killing all stocks
0 · Reply
Mikemelga2024
Mikemelga2024 Nov. 20 at 10:07 PM
$ADIL waiting with 50000 shares 🤷‍♂️
0 · Reply
Patrik605
Patrik605 Nov. 20 at 5:52 PM
$ADIL For me, this company has a relatively high chance of success. In this time of uncertainty and war, I think there will be more and more people who need help with this addiction. And I would say that some holders of this stock too. 😁
0 · Reply
dogood
dogood Nov. 20 at 1:03 PM
$ADIL see that $ENSC positive fda feedback , shall we get the same here today
1 · Reply
Perfect_Thinking
Perfect_Thinking Nov. 19 at 6:42 PM
$ADIL This stock need more than pataints, its like dropping from clif and again flying on same place where it was dropped, it needs a PR like final phase updates for FDA to cross 1.50 im dec 2nd week, till than its a dead cow waiting for more slaughtered...
1 · Reply
David_M_
David_M_ Nov. 19 at 2:14 PM
$ADIL hopeful
0 · Reply
Mikemelga2024
Mikemelga2024 Nov. 19 at 1:26 PM
$ADIL Premarket 🫣😢
0 · Reply
dogood
dogood Nov. 18 at 11:33 PM
$ADIL look at $KZIA
1 · Reply